Anticoagulated patients facing high-risk endoscopic procedures might benefit from a switch from warfarin to a direct oral anticoagulant (DOAC), new research suggests. A Japanese study of almost 17,000 patients found a significantly higher risk of gastrointestinal bleeding within 30 days of the procedure in patients on warfarin (12%) compared to DOACs (9.9%). The study also ...
DOACs better than warfarin for GI endoscopy
By Mardi Chapman
14 Sep 2017